Shandong Xinhua Pharmaceutical Co (FRA:XIN) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:XIN Shandong Xinhua Pharmaceutical Co Ltd FRA:XIN
83 GF Score
Price €0.58
GF Value €0.72
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Shandong Xinhua Pharmaceutical Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Shandong Xinhua Pharmaceutical Co  (FRA:XIN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Xinhua Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Shandong Xinhua Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 1.50 0.97 0.96 0.90

Shandong Xinhua Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 1.05 0.90 0.88 0.76

FRA:XIN vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Xinhua Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


FRA:XIN
83GF Score
Shandong Xinhua Pharmaceutical Co Ltd FRA:XIN
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Xinhua Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shandong Xinhua Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Shandong Xinhua Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.021/116.0564*116.0564
=1.021

Current CPI (Jun. 2026) = 116.0564.

Shandong Xinhua Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201603 0.450 102.200 0.511
201609 0.460 102.400 0.521
201703 0.487 103.200 0.548
201706 0.483 103.100 0.544
201709 0.493 104.100 0.550
201712 0.530 104.500 0.589
201803 0.544 105.300 0.600
201806 0.557 104.900 0.616
201809 0.557 106.600 0.606
201812 0.573 106.500 0.624
201903 0.619 107.700 0.667
201906 0.603 107.700 0.650
201909 0.624 109.800 0.660
201912 0.640 111.200 0.668
202003 0.654 112.300 0.676
202006 0.638 110.400 0.671
202009 0.653 111.700 0.678
202012 0.682 111.500 0.710
202103 0.695 112.662 0.716
202106 0.733 111.769 0.761
202109 0.764 112.215 0.790
202112 0.803 113.108 0.824
202203 0.856 114.335 0.869
202206 0.869 114.558 0.880
202209 0.901 115.339 0.907
202212 0.875 115.116 0.882
202303 0.904 115.116 0.911
202306 0.851 114.558 0.862
202309 0.901 115.339 0.907
202312 0.904 114.781 0.914
202403 0.937 115.227 0.944
202406 0.936 114.781 0.946
202409 0.954 115.785 0.956
202412 1.012 114.893 1.022
202503 0.998 115.116 1.006
202506 0.925 114.907 0.934
202509 0.934 115.471 0.939
202512 0.964 115.832 0.966
202603 1.009 116.303 1.007
202606 1.021 116.056 1.021

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Shandong Xinhua Pharmaceutical Co (FRA:XIN) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Xinhua Pharmaceutical Co stock appears to be undervalued. The current stock price of €0.58 is trading 19.4% below its estimated GF Value™ of €0.72. GuruFocus considers Shandong Xinhua Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for FRA:XIN:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €0.72 vs. price of €0.58 (19.4% below fair value)
  • GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the FRA:XIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Xinhua Pharmaceutical Co Business Description

Other Exchanges 00719:Hong Kong000756:China
Address No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.
83GF Score

Get the complete analysis for FRA:XIN

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.58
Price
€0.72
GF Value